Reduced Medicare reimbursements that took effect April 1 due to sequestration have led cancer clinics nationwide to reject Medicare patients, according to a report by the Washington Post.
At issue are expensive chemotherapy drugs that make the lower reimbursements inadequate to keep the clinics' balance sheets solvent. As a result, some cancer patients on Medicare will need to seek treatment at other clinics and hospitals, according to the report.
3 Years of PPACA: The 5 Biggest Changes in Healthcare Since the Law's Passage
Congress Avoids Government Shutdown, Passes Budget With $2.7T in Healthcare Savings
At issue are expensive chemotherapy drugs that make the lower reimbursements inadequate to keep the clinics' balance sheets solvent. As a result, some cancer patients on Medicare will need to seek treatment at other clinics and hospitals, according to the report.
More Articles on Medicare Reimbursements:
Hospitals Brace for Sizable Medicare Cuts From Sequestration3 Years of PPACA: The 5 Biggest Changes in Healthcare Since the Law's Passage
Congress Avoids Government Shutdown, Passes Budget With $2.7T in Healthcare Savings